The Taub Foundation Grants Program for Myelodysplastic Syndromes (MDS) Research was created to support high-impact, innovative translational research to understand the underlying causes of MDS and to advance its treatment and prevention. The Program specifically focuses on MDS research, exclusive of AML and MPN. Studies focusing on molecular genetics, epigenetics, splicing factors, stem cells, the microenvironment and novel therapeutic targets relevant to MDS are encouraged.
Innovative studies with transformative potential to elucidate MDS etiology and to develop new treatments are particularly encouraged.
The Taub Program supports independent investigators at all stages of their careers. To promote the expansion of the MDS research field collaborative efforts and proposals from young investigators and those from non-MDS fields are encouraged to apply.
Three-year awards of $600,000 ($200,000 per year, inclusive of 10% indirect costs) will be made to independent investigators working in non-profit, non-governmental academic, medical, or research institutions within the United States. Collaborative efforts are encouraged.
Deadline: Oct. 15, 2019
All applicants must meet the following eligibility requirements: Initial Proposal Deadline: Thursday, November 8, 2018 12:00 Noon, U.S. ET Application Guidelines, Terms of the Award & Submission Instructions The Taub Foundation Grants Program for MDS Research Page 2 • Hold a Ph.D., MD, M.D./Ph.D., or comparable degree, and a faculty appointment at a non-profit, academic, medical, or research institution in the United States. • All applicants must be independent investigators with demonstrated institutional support and their own laboratory space to conduct the proposed research. • Applicants may not have funding support for a similar project. • Applicants may only submit one application as a PI. • Applicants do not need to be nominated by their institutions. • United States citizenship is not required; visa documentation is not required.
